Ecromeximab
- Generic Name
- Ecromeximab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 292819-64-8
- Unique Ingredient Identifier
- M76FX2JZRM
- Background
Ecromeximab has been used in trials studying the treatment of Cutaneous Melanoma and Metastatic Melanoma.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath